Several weight-loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan Stanley (MS) analysts.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today )
Also on site :
- Trump advisor expects China trade deal conclusion Monday
- China’s Exports of Rare Earths Jump Despite Shipment Controls
- U.S. Rooftop Solar Giant Sunnova Files for Bankruptcy